Finance

Beta
Lists
PBSV:OTCMKTS
Pharma-Bio Serv Inc
$0.53
-7.01%
(-0.040) 1D
Jun 4, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PBSV...
Open
$0.53
High
$0.53
Low
$0.53
Mkt. cap
12.03M
Avg. vol.
617.00
Volume
1.02K
52-wk high
$1.36
52-wk low
$0.43
EPS
-$0.00
Beta
0.67
Shares outstanding
22.90M
No. of employees
55
Open
$0.53
High
$0.53
Low
$0.53
Mkt. cap
12.03M
Avg. vol.
617.00
Volume
1.02K
52-wk high
$1.36
52-wk low
$0.43
EPS
-$0.00
Beta
0.67
Shares outstanding
22.90M
No. of employees
55
News stories
From sources across the web
About Pharma-Bio Serv Inc
CEO-
Employees55
Founded1993
Headquarters-
SectorHealth care
Websitepbsvinc.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Revenue
2.42M
1.96M
2.15M
2.29M
Cost of goods sold
1.60M
1.39M
1.40M
1.57M
Cost of revenue
1.60M
1.39M
1.40M
1.57M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
917.05K
888.14K
882.21K
816.91K
Operating expense
917.05K
888.14K
882.21K
816.91K
Total operating expenses
2.52M
2.28M
2.28M
2.39M
Operating income
-98.32K
-313.88K
-133.27K
-94.54K
Other non operating income
-
104.85K
-405.88K
131.02K
EBT including unusual items
100.86K
-209.03K
4.25K
36.49K
EBT excluding unusual items
100.86K
-209.03K
4.25K
36.49K
Income tax expense
5.51K
-4.78K
4.36K
3.63K
Effective tax rate
5.46%
2.29%
102.40%
9.95%
Other operating expenses
-
-
-
-
Net income
95.35K
-204.25K
-102.00
32.86K
Net profit margin
3.94%
-10.40%
-
1.43%
Earnings per share
0.00
-0.01
-
0.00
Interest and investment income
299.19K
-
643.40K
-
Interest expense
-
-
-
-
Net interest expenses
299.19K
-
643.40K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-79.46K
-298.13K
-117.46K
-79.74K
Gain or loss from assets sale
-
-
-
-7.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer